Literature DB >> 12174374

Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Fu-Hua Yan1, Kang-Rong Zhou, Jie-Min Cheng, Jian-Hua Wang, Zhi-Ping Yan, Reng-Rong Da, Jia Fan, Yuan Ji.   

Abstract

AIM: To evaluate the role and limitation of fast multiplanar spoiled gradient-recalled (FMPSPGR) MR dynamic contrast scanning in the follow-up of patients with HCC treated by transarterial chemoembolization (TACE).
METHODS: Twenty-two patients with 24 HCC lesions confirmed by biopsy or surgical resection underwent MR imaging in 4-9wks after TACE with a superconducting 1.5 T MR scanner, including SE T(1)WI, T(2)WI and FMPSPGR dynamic contrast scanning. The signal intensities of all lesions on SE T(1)WI,T(2)WI and the enhancement patterns on FMPSPGR dynamic contrast scanning were observed, and the comparison was made between MRI findings and pathological results in all the cases.
RESULTS: Of the 24 lesions, the signal intensities were various on SE T(1)WI and T(2)WI. On T(1)WI, 13 lesions appeared as hyperintense, 4 lesions were isointense and the other 7 lesions were hypointensese. Histologically, hyperintense lesions showed on T(1)WI were viable tumor or hemorrhage; isointensities were coagulative necrosis or inflammatory infiltration; hypointensities were tumor, liquified necrosis, coagulative necrosis or inflammatory infiltration. On T(2)WI, 15 lesions appeared as hyperintense, 3 lesions were isointense and the other 6 lesions were hypointensese. Hyperintense lesions showed on T(2)WI were residuals of viable tumor, hemorrhage, liquefied necrosis or inflammatory infiltration; isointense lesions were residuals of viable tumor or inflammatory infiltration; hypointense lesions were coagulative necrosis. On FMPSPGR dynamic contrast scanning, 18 of the 24 lesions enhanced on early-phase dynamic scanning corresponding to residuals of viable tumor and the other 6 lesions had no enhancement at this phase because complete necrosis were seen in the histologic examination. On delayed-phase dynamic scanning, 6 lesions had permanent enhancement appeared as inhomogeneous hyperintensity and both residuals of viable tumor and inflammatory infiltration were found by histologic examination. 18 lesions were hypointense at this phase and 8 of them coexisted with peripheral ring-like enhancement of the lesions resulting from viable tumors or inflammatory infiltration.
CONCLUSION: FMPSPGR MR dynamic contrast scanning can reflect the pathologic changes of HCC treated by TACE. Especially, early-phase dynamic scanning can evaluate accurately residuals of viable tumor and necrosis in HCC lesions. FMPSPGR dynamic contrast scanning is useful in the follow-up of patients with HCC treated by TACE combined with SE T(1)WI and T(2)WI, but it is difficult to differentiate peripheral viable tumors from inflammatory infiltration.

Entities:  

Mesh:

Year:  2002        PMID: 12174374      PMCID: PMC4656316          DOI: 10.3748/wjg.v8.i4.658

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

Review 1.  Treatment of hepatocellular carcinoma by interventional methods.

Authors:  T Livraghi
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Progress in research of liver surgery in China.

Authors:  Meng-Chao Wu; Feng Shen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 3.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; S L Ye
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

5.  [Multiphasic helical computerized tomography of hepatocarcinoma. Assessment after chemoembolization].

Authors:  O Catalano; M Esposito; F Sandomenico; A Nunziata; A Siani
Journal:  Radiol Med       Date:  2000-06       Impact factor: 3.469

6.  Arterial chemoembolization for hepatocellular carcinoma.

Authors:  Jian Fan; Gao-Jing Ten; Shi-Cheng He; Jin-He Guo; Dong-Pei Yang; Guo-Ying Wang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

7.  Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization--preliminary findings.

Authors:  R C Semelka; S Worawattanakul; M A Mauro; S A Bernard; W G Cance
Journal:  J Magn Reson Imaging       Date:  1998 Jan-Feb       Impact factor: 4.813

Review 8.  Diagnostic imaging and interventional therapy of hepatocellular carcinoma.

Authors:  L D Palma
Journal:  Br J Radiol       Date:  1998-08       Impact factor: 3.039

9.  Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology.

Authors:  K Ito; K Honjo; T Fujita; M Matsui; H Awaya; T Matsumoto; N Matsunaga; T Nakanishi
Journal:  J Comput Assist Tomogr       Date:  1995 Mar-Apr       Impact factor: 1.826

10.  Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC.

Authors:  G Pelletier; M Ducreux; F Gay; M Luboinski; H Hagège; T Dao; W Van Steenbergen; C Buffet; P Rougier; M Adler; J P Pignon; A Roche
Journal:  J Hepatol       Date:  1998-07       Impact factor: 25.083

View more
  11 in total

1.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced Ultrasound.

Authors:  Kibo Nam; Maria Stanczak; Andrej Lyshchik; Priscilla Machado; Yuko Kono; Flemming Forsberg; Colette M Shaw; John R Eisenbrey
Journal:  Biomed Phys Eng Express       Date:  2018-04-18

Review 3.  Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.

Authors:  Matthew P Lungren; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh Thakor; Richard B Towbin; Anne Marie Cahill; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2018-01-23

4.  Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response.

Authors:  Ipek Oezdemir; Corrine E Wessner; Colette Shaw; John R Eisenbrey; Kenneth Hoyt
Journal:  Ultrasound Med Biol       Date:  2020-06-16       Impact factor: 2.998

5.  Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma.

Authors:  Yang Hai; Esika Savsani; Weelic Chong; John Eisenbrey; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-08-19

Review 6.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

Authors:  Xiao-Feng Liao; Ji-Lin Yi; Xing-Rui Li; Wei Deng; Zhi-Fang Yang; Geng Tian
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.

Authors:  Jun-Gong Zhao; Gan-Sheng Feng; Xiang-Quan Kong; Xin Li; Ming-Hua Li; Ying-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.

Authors:  Jun Qian; Jochen Truebenbach; Florian Graepler; Philippe Pereira; Peter Huppert; Thomas Eul; Gundula Wiemann; Claus Claussen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 10.  Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies.

Authors:  John R Eisenbrey; Helena Gabriel; Esika Savsani; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.